References
- Taskforce on hypertension in pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013 Nov;122(5):1122–31.
- Fidler J, Smith V, De Swiet M. A randomized study comparing timolol and methyldopa in hospital treatment of puerperal hypertension. Br J Obstet Gynaecol 1982 Dec;89(12):1031–4.
- Griffis KR Jr, Martin JN Jr, Palmer SM, et al. Utilization of hydralazine or alpha-methyldopa for the management of early puerperal hypertension. Am J Perinatol 1989 Oct;6(4):437–41.
- Vigil-De Gracia P, Ruiz E, López JC, et al. Management of severe hypertension in the postpartum period with intravenous hydralazine or labetalol: a randomized clinical trial. Hypertens Pregnancy 2007;26(2):163–71.
- Vermillion ST, Scardo JA, Newman RB, Chauhan SP. A randomized, double-blind trial of oral nifedipine and intravenous labetalol in hypertensive emergencies of pregnancy. Am J Obstet Gynecol 1999 Oct;181(4):858–61.
- Sibai BM. Etiology and management of postpartum hypertension-preeclampsia. Am J Obstet Gynecol 2012 Jun;206(6):470–5.
- Magee L, von Dadelszen P. Prevention and treatment of postpartum hypertension. Cochrane Database Syst Rev 2013 Apr 30;4:CD004351.